Jasmina Anema, 6 Year Old who Inspired Thousands (and me), Dies

Damn.
Double Damn.

Jasmina Anema, the Manhattan girl whose brave battle against leukemia captivated the city and inspired thousands to become bone marrow donors, has died. She was just six years old.
Jasmina's year-long fight against an especially fatal form of the disease ended at 10:55 p.m. Wednesday night at NYU Langone Medical Center, her mother, Thea Anema, said.

Suffering from a fever and shortness of breath, Jasmina was admitted to the hospital Monday morning. She was diagnosed with pneumonia in both of her lungs, and her condition deteriorated rapidly. Before noon on Wednesday, doctors moved Jasmina into the ICU because her breathing had become so labored. She only got worse.

She became well-known when Rihanna publicized her story, as did some other well-known celebrities.

Hope seemed lost until early May, when a near-perfect donor match was finally found.
The resulting transplant was a success, but Jasmina's good fortune did not last.

A biopsy in September revealed that her cancer had returned. By that point, Jasmina was also suffering from graft versus host disease, a common complication in bone-marrow transplants in which the new cells attack the recipient's body.

I fell in love with this little girl when a friend pointed me to her webpage last summer at http://www.oneforjasmina.com. Go there now and read about her visit with President Obama.
She inspired thousands of people to become bone marrow donors.
Including me.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap